This category as a whole has been affected by supply chain issues for some time, so hopefully now you know what to use when, and have backup products in mind if your favorites are unavailable
For individuals without insurance coverage, we offer self-pay options to ensure access to this beneficial treatment
Just putting it out there just in case
No AOD-9604 is not FDA-approved and remains a research-only peptide
3.5 AI identification Among the 63 samples, three AI APIs (anastrozole, letrozole, and exemestane) were identified using LC-QTOF-MS/MS (Table 2)
What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
